Back

The genetic background of the disease in a group of patients with severe course of hypertrophic cardiomyopathy.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Cardiac hypertrophy Cardiomyopathies ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Mariusz Klopotowski

Institute of Cardiology, Warsaw (Poland)

11 More presentations in this session

Presentation thumbnail
Glutamine-fructose-6-phosphate amidotransferase 2 mediates isoproterenol-induced cardiac hypertrophy by increasing Akt O-GlcNAcylation through hexosamine biosynthesis pathway
Doctor A. Ishikita (Fukuoka, JP)
Abstract
Presentation thumbnail
Epigenetic modifications via histone acetylation by p300 are changed during the transition from cardiac hypertrophy to heart failure
Mr Y. Sunagawa (Shizuoka, JP)
Abstract
Presentation thumbnail
Inhibition of GATA4 dimerization suppress hypertrophic responses
Mr S. Shimizu (Shizuoka, JP)
Abstract
Presentation thumbnail
Adverse left ventricular remodeling in descending thoracic vs ascending aorta banding in novel porcin model. cMRI study
Doctor S. Popevska (Leuven, BE)
Abstract Slides
Presentation thumbnail
Non-invasive predictors of LV biopsy-obtained creatine kinase activity in patients with non-failing and failing myocardial hypertrophy
Doctor M. Peterzan (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Cardiac hypertrophy

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Session
When time is the issue
thumbnail
Congress Session
Genetics in heart failure
thumbnail
Congress Session
When external causes are the villain?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources